Open Access Animal Physiology
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
An Author's Guide
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
A correlation of haloperidol-induced cognitive deficit with dysfunctional dopamine receptor activity in nonhuman primate
(5548) Total Article Views
Authors: Irene Navarro-Lobato, Mariam Masmudi-Martín, Manuel F López-Aranda, et al
Published Date May 2010
Volume 2010:2 Pages 1 - 8
Irene Navarro-Lobato1,2, Mariam Masmudi-Martín1, Manuel F López-Aranda1,2,3, Juan Félix López-Téllez1,2,3, Zafar U Khan1,2,3
1Laboratory of Neurobiology at CIMES, Department of Medicine, Faculty of Medicine, University of Málaga, Málaga, Spain; 2Department of Medicine, Faculty of Medicine, University of Málaga, Málaga, Spain; 3CIBERNED, Institute of Health Carlos III, Madrid, Spain
Abstract: Haloperidol is an antipsychotic drug that acts through blockage of dopamine D2 receptors. Chronic administration of this antipsychotic drug in nonhuman primates induces a pronounced cognitive deficit. However, receptor subtypes that are responsible for this cognitive dysfunction remain unknown. Therefore, brains of chronic haloperidol-treated young and aged monkeys were used to analyze the intricate relation of receptor activity, cognitive dysfunction, and haloperidol-mediated actions in the production of harmful effects. Taking into account the significant cognitive loss observed after haloperidol treatment, it was predicted that changes in the cognitive status that correlate with the receptor activity in the prefrontal cortex and striatum, areas implicated in the processing of haloperidol-mediated effects in brain, should be common in both young and aged animals. Based on this concept, we observed that in the prefrontal cortex, dopamine D1 and D2 receptors showed changes in receptor levels that were common in both age groups. However, this relationship was absent in GABAA, serotonin 5HT2 and muscaranic receptors. In contrast to the prefrontal cortex, in striatum, this change was restricted to the dopamine D2 receptors only. Therefore, from our results, it seems that apart from the downregulation of D1 receptor activity in the prefrontal cortex, an upregulation of D2 receptors could also contribute to the generation of the cognitive loss observed in haloperidol-treated monkeys. Additionally, reduced excitatory input due to hampered cortico-striatal D1 dopaminergic activity and stronger inhibition at the synapse of excitatory input site by upregulated striatal D2 receptor activity could promote the side effects associated with haloperidol.
Keywords: cognitive deficit, nonhuman primates, haloperidol, antipsychotic drug, receptor activity
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter
Readers of this article also read:
Call For Submissions
Submit Original Research Article, Review, Case Report, or Rapid Communication in Open Access Animal Physiology
- Evolution of a domain conserved in microtubule-associated proteins of eukaryotes
- Overview of the LDL receptor: relevance to cholesterol metabolism and future approaches for the treatment of coronary heart disease
- Is gene activity in plant cells affected by UMTS-irradiation? A whole genome approach
- Discrimination between biological interfaces and crystal-packing contacts